Skip to main content
. 2015 Oct 19;6(35):37054–37065. doi: 10.18632/oncotarget.6163

Figure 3. The diabetic environment enhances ECM expression by ISCs.

Figure 3

A. Immunofluorescent staining of ISCs for Col-I, Col-III and FN. Scale bar = 20μm. B. qRT-PCR and Western blotting measurements of mRNA and protein expression of Col-I, Col-III and FN in ISCs. Data are expressed as mean ± SE (n = 3), * P< 0.05, ** P< 0.01, db/db ISCs vs. db/m ISCs.